Literature DB >> 19267050

[Perspectives and challenges to guarantee training and renewal in general internal medicine].

G Waeber1, J Cornuz, J-M Gaspoz, A Pécoud, A Perrier.   

Abstract

Training new doctors in general internal medicine represents a challenge. This requires to define future needs, which result from interest that are not necessarily convergent between patients, doctors, insurers and politicians. Problems related to medical demography in Switzerland, with the ageing of the population, the increase in health care costs and the place of Switzerland within the European Community require the implementation of specific objectives to train new physicians in general internal medicine. The success of these opportunities depends on social factors, political choices and choices from physician's association. In this article we will approach these challenges by formulating some proposals--nonexhaustive--in order to guarantee sufficient renewal in general internal medicine.

Entities:  

Mesh:

Year:  2009        PMID: 19267050

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  4 in total

1.  Determinants of internal medicine residents' choice in the Canadian R4 fellowship match: a qualitative study.

Authors:  Vijay J Daniels; Narmin Kassam
Journal:  BMC Med Educ       Date:  2011-06-29       Impact factor: 2.463

2.  Primary care in Switzerland: evolution of physicians' profile and activities in twenty years (1993-2012).

Authors:  Christine Cohidon; Jacques Cornuz; Nicolas Senn
Journal:  BMC Fam Pract       Date:  2015-08-21       Impact factor: 2.497

3.  Impact of personal goals on the internal medicine R4 subspecialty match: a Q methodology study.

Authors:  Vijay J Daniels; Narmin Kassam
Journal:  BMC Med Educ       Date:  2013-12-21       Impact factor: 2.463

4.  Participation in medical activities beyond standard consultations by Swiss general practitioners: a cross-sectional study.

Authors:  Julian Jakob; Christine Cohidon; Jacques Cornuz; Kevin Selby
Journal:  BMC Fam Pract       Date:  2018-05-03       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.